AGP Executive Report
Last update: 8 hours agoFed Watch: The Federal Reserve held rates steady but signaled a hawkish tilt under new chair Kevin Warsh, with more policymakers backing a hike later in 2026—sending stocks down and bond yields up. AI & Jobs: Major tech firms are cutting large numbers of workers to fund AI infrastructure that still isn’t delivering clear results yet, fueling a widening gap between AI hype and business outcomes. NYC Power & Climate: A new cross-border hydropower line (Champlain Hudson Power Express) is now feeding New York’s grid, boosting cleaner electricity supply for the NYC metro area. Biotech Moves (NY): Bronx-based Oligomerix won an NIH Fast Track Phase II grant for an oral Alzheimer’s drug candidate, while Latham’s AngioDynamics got FDA IDE approval to start a NanoKnife study for BPH. Tech Policy: New York’s stop-arm school bus camera plan is being pulled back after limited safety gains in testing. Health & Food: Cameroon’s nutrition experts are pushing “produce prescriptions” to tackle diet-linked diabetes and hypertension. Space/Markets: SpaceX shares surged after its Nasdaq IPO, with Musk’s valuation topping major rivals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
